Access National – All Time High
May 13, 2015
Jeremy Parkinson
Finance
The Chart of the Day is Access National (NASDAQ:ANCX) . I found the stock buy sorting the All Time High list for the stock with the best technical buy signals, then used the Flipchart feature to review the charts. Since the Trend Spotter signaled a buy on 1/13 the stock gained 11.47%. Access National Corporation serves as the holding company for […]
Import And Export Price Year-Over-Year Deflation Continues In April 2015. Much Less Deflation Was Expected By The Markets
May 13, 2015
Jeremy Parkinson
Finance
Global trade prices continue to deflate year-over-year. Import prices are down 10.7% from a year ago, while export prices are down 6.3%. The market was expecting much less deflation. Import Oil prices were up 0.7% month-over-month, but export agricultural prices fell 0.8%. with import prices down 0.3% month-over-month,down 10.7% year-over-year; and export prices down 0.7% month-over-month, down 6.3% year-over-year.. the markets […]
SP 500 And NDX Futures Daily Charts – History Repeats – Grapes Of Wrath
May 13, 2015
Jeremy Parkinson
Finance
Export-Import prices this morning came in weakly, showing little upward pressure on monetary inflation. Retail sales however came in badly and that gave the markets the shakes. The Atlanta Fed’s model of forward GDP is showing 2Q at about 0.7 percent. Hardly the kind of number favoring a policy of tightening. And so the dollar […]
Cisco Systems, Inc. Edges Out Earnings Estimates
May 13, 2015
Jeremy Parkinson
Finance
Cisco Systems, Inc. (NASDAQ:CSCO) Systems released the earnings results from its third quarter of fiscal 2015 after closing bell tonight, posting non-GAAP earnings of 54 cents per share or $2.8 billion on $12.1 billion in revenue, a 5% increase from last year. Analysts had been expecting earnings of 53 cents per share and $12.07 billion in […]
Less ‘Goldilocks’, More ‘Three Bears’: Bullion Bid As Stocks & Bonds Skid
May 13, 2015
Jeremy Parkinson
Finance
The correlation between stocks and bond yields continues to have regime-shifted to approach -1 (not 1 – as is more ‘normal’) confounding asset allocators and risk parity funds across the market… This seemed appropriate… If that analogy didn’t help, maybe this will clear things up… Small investor, shown here on right, with cash on the […]
Financial Repression Authority With Richard Duncan
May 13, 2015
Jeremy Parkinson
Finance
US Nearing Recession, Dollar Falling Hard
May 13, 2015
Jeremy Parkinson
Finance
The dollar soars by a record amount versus the euro and the yen in 2014. And economists predict strong growth in 2015. Really? If a country can have a rapidly-appreciating currency with all the benefits that that confers, and strong economic growth with all the obvious advantages that that confers, why wouldn’t everyone be going for powerhouse […]
John Williams: Get Ready For New Recession
May 13, 2015
Jeremy Parkinson
Finance
John Williams of ShadowStats.com shares Peter Schiff’s expectation of a new round of quantitative easing from the Federal Reserve. Williams believes the United States economy is slowing down and headed into another recession. He sees inflation rising in the coming years as the markets realize that the Federal Reserve is incapable of actually helping the […]
The One That Got Away
May 13, 2015
Jeremy Parkinson
Finance
Watching the EUR/USD zoom higher is just a heartbreaker, because this was one of the great contrarian plays of the past several years. The EUR/USD was hated by one and all, and parity seemed like a foregone conclusion. But, as always, just when things seemed bleakest, it began a powerful reversal, and frankly, it could […]
Hot Biotech Sector: Mid-Caps Have Both M&A And Pipeline Premiums
May 13, 2015
Jeremy Parkinson
Finance
Valuations Step-Up With More Deals Prior to the acquisition of Pharmacyclics (PCYC) by Abbvie (ABBV) for $20B, the top price paid for an emerging biotech company was in the $10B range. Two additional companies among the mid-caps were acquired in prior years: Cubist (CBST) by Merck (MRK) in December 2014 and Onyx (ONXX) by Amgen (AMGN) in […]